Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
Clinical trial NCT04616963 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04616963
- Sponsor
- University of California, San Diego
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-24
- Primary completion
- 2024-01-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.